Publicaciones en colaboración con investigadores/as de Centre National de la Recherche Scientifique (80)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Dopamine D4 receptor is a regulator of morphine-induced plasticity in the rat dorsal striatum

    Cells, Vol. 11, Núm. 1

  2. FOSL2 truncating variants in the last exon cause a neurodevelopmental disorder with scalp and enamel defects

    Genetics in Medicine, Vol. 24, Núm. 12, pp. 2475-2486

  3. Microwave-Assisted 1,3-Dioxa-[3,3]-Sigmatropic Rearrangement of Substituted Allylic Carbamates: Application to the Synthesis of Novel 1,3-Oxazine-2,4-dione Derivatives

    European Journal of Organic Chemistry, Vol. 2022, Núm. 1

  4. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 21

2021

  1. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

    Science immunology, Vol. 6, Núm. 62

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

    eLife, Vol. 10

  4. Serotonergic control of the glutamatergic neurons of the subthalamic nucleus

    Progress in Brain Research (Elsevier B.V.), pp. 423-462

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Cannabinoid control of olfactory processes: The where matters

    Genes, Vol. 11, Núm. 4

  3. Editorial: Non-Dopaminergic Systems in Parkinson’s Disease

    Frontiers in Pharmacology

  4. Group therapy for adolescents and parents: Study of unconscious orientation

    NeuroQuantology, Vol. 18, Núm. 7, pp. 70-82

  5. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  6. The Noradrenergic System in Parkinson’s Disease

    Frontiers in Pharmacology, Vol. 11

2019

  1. Dysfunction of serotonergic neurons in Parkinson's disease and dyskinesia

    International Review of Neurobiology (Academic Press Inc.), pp. 259-279

  2. Environmental enrichment shapes striatal spike-timing-dependent plasticity in vivo

    Scientific Reports, Vol. 9, Núm. 1

  3. Second-hand smoke exposure in adulthood and lower respiratory health during

    Respiratory Research, Vol. 20, Núm. 1

  4. Sediment Respiration Pulses in Intermittent Rivers and Ephemeral Streams

    Global Biogeochemical Cycles, Vol. 33, Núm. 10, pp. 1251-1263